44 related articles for article (PubMed ID: 19318798)
1. Myxoinflammatory fibroblastic sarcoma: a clinicopathologic analysis of 104 cases, with emphasis on predictors of outcome.
Laskin WB; Fetsch JF; Miettinen M
Am J Surg Pathol; 2014 Jan; 38(1):1-12. PubMed ID: 24121178
[TBL] [Abstract][Full Text] [Related]
2. The immunohistochemical characterization of sarcomatoid malignant mesothelioma of the pleura.
Chirieac LR; Pinkus GS; Pinkus JL; Godleski J; Sugarbaker DJ; Corson JM
Am J Cancer Res; 2011; 1(1):14-24. PubMed ID: 21969119
[TBL] [Abstract][Full Text] [Related]
3. High-level expression of podoplanin in benign and malignant soft tissue tumors: immunohistochemical and quantitative real-time RT-PCR analysis.
Xu Y; Ogose A; Kawashima H; Hotta T; Ariizumi T; Li G; Umezu H; Endo N
Oncol Rep; 2011 Mar; 25(3):599-607. PubMed ID: 21234520
[TBL] [Abstract][Full Text] [Related]
4. Differential gene expression profiles of neurothekeomas and nerve sheath myxomas by microarray analysis.
Sheth S; Li X; Binder S; Dry SM
Mod Pathol; 2011 Mar; 24(3):343-54. PubMed ID: 21297585
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa.
Sachdev R; Sundram U
J Cutan Pathol; 2006 May; 33(5):353-60. PubMed ID: 16640542
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms.
Jokinen CH; Dadras SS; Goldblum JR; van de Rijn M; West RB; Rubin BP
Am J Clin Pathol; 2008 Jun; 129(6):886-93. PubMed ID: 18480004
[TBL] [Abstract][Full Text] [Related]
7. Podoplanin expression in fibrous histiocytomas and cellular neurothekeomas.
Kaddu S; Leinweber B
Am J Dermatopathol; 2009 Apr; 31(2):137-9. PubMed ID: 19318798
[TBL] [Abstract][Full Text] [Related]
8. Fibrous and fibrohistiocytic neoplasms: an update.
Clarke LE
Dermatol Clin; 2012 Oct; 30(4):643-56, vi. PubMed ID: 23021051
[TBL] [Abstract][Full Text] [Related]
9. [Fibrohistiocytic skin tumors].
Hügel H
J Dtsch Dermatol Ges; 2006 Jul; 4(7):544-55. PubMed ID: 16827912
[TBL] [Abstract][Full Text] [Related]
10. The role of podoplanin in tumor progression and metastasis.
Raica M; Cimpean AM; Ribatti D
Anticancer Res; 2008; 28(5B):2997-3006. PubMed ID: 19031946
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous fibrohistiocytic tumours - an update.
Luzar B; Calonje E
Histopathology; 2010 Jan; 56(1):148-65. PubMed ID: 20055912
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
